Grass Pollen Allergy
📧 Sign up to get email alerts when something new happens for Grass Pollen Allergy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-27Clinical Trial Update: Grass Pollen Immunotherapy Plus Dupilumab for Tolerance Induction [Phase 2]
Phase 2 trial evaluating grass pollen immunotherapy in combination with dupilumab for tolerance induction in allergic rhinoconjunctivitis an…
-
CLINICAL_TRIALS trial_result · 2026-04-27Clinical Trial Results: Grass Pollen Immunotherapy Plus Dupilumab for Tolerance Induction [Phase 2]
Phase 2 trial evaluating grass pollen immunotherapy combined with dupilumab for tolerance induction in allergic rhinoconjunctivitis and gras…
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: GRASS (Grass MATA MPL Real-world Assessment Study)
GRASS is an ongoing real-world assessment evaluating Grass MATA MPL for grass pollen allergy. The study is currently recruiting.
-
CLINICAL_TRIALS research · 2025-09-04Clinical Trial Update: Creating A Risk Assessment Tool for Thunderstorm Asthma: the CARISTA Study [NA]
The CARISTA study at the University of Melbourne is currently recruiting participants to develop a risk assessment tool for thunderstorm-rel…
-
CLINICAL_TRIALS trial_result · 2025-07-15Clinical Trial Update: Grass Pollen Immunotherapy Plus Dupilumab for Tolerance Induction [Phase 2]
Phase 2 trial evaluating grass pollen immunotherapy in combination with dupilumab for tolerance induction in grass pollen allergy-related al…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-07-13Clinical Trial Update: Assessment of the Contribution of Monophosphoryl Lipid A (MPL) to a Grass Pollen Allergy Vaccine [Phase 2]
Phase 2 clinical trial evaluating the contribution of Monophosphoryl Lipid A (MPL) to a grass pollen allergy vaccine has completed.
-
CLINICAL_TRIALS trial_result · 2017-01-19Clinical Trial Update: Effect of Different Pre-seasonal BM32 Dosings on the Induction of a Protective Immune Response [Phase 2]
Phase 2 trial evaluating different pre-seasonal BM32 dosing regimens to induce a protective immune response. The study status is completed.
-
CLINICAL_TRIALS research · 2016-11-17Clinical Trial Update: Specific Immunotherapy for Allergic Child [NA]
Clinical trial update on a specific immunotherapy for allergic children addressing allergic rhinitis, asthma, and grass pollen allergy; curr…
-
CLINICAL_TRIALS trial_result · 2016-09-14Clinical Trial Update: Grass Sensitisation and Allergic Rhinitis in Thai Patients
This completed clinical trial in Thai patients evaluated grass pollen sensitisation and allergic rhinitis related to weed pollens.
-
CLINICAL_TRIALS trial_result · 2016-05-25Clinical Trial Update: Safety and Efficacy on Phase III Study on 300 IR SLIT to Patients Suffering From Grass Pollen Rhinoconjunctivitis [Phase 3]
Phase III trial evaluating the safety and efficacy of a 300 IR grass pollen sublingual immunotherapy (SLIT) for grass pollen rhinoconjunctiv…
-
CLINICAL_TRIALS trial_result · 2016-05-23Clinical Trial Update: Safety and Efficacy of Sublingual Immunotherapy (SLIT) Tablets in Grass Pollen Rhinoconjunctivitis [Phase 2, Phase 3]
Phase 2/3 trials assess the safety and efficacy of sublingual immunotherapy tablets for grass pollen–induced allergic rhinoconjunctivitis; r…
-
CLINICAL_TRIALS trial_result · 2015-12-18Clinical Trial Update: Phase II Study of Grass Pollen Allergy Vaccine BM32 [Phase 2]
Phase II clinical trial evaluating BM32, a grass pollen allergy vaccine developed by Biomay AG, has completed.
-
CLINICAL_TRIALS trial_result · 2015-05-12Clinical Trial Update: Grass Pollen Subcutaneous Immunotherapy in Elderly Patients [Phase 4]
Phase 4 trial completed evaluating grass pollen subcutaneous immunotherapy in elderly patients with grass pollen allergy. The study focused …
-
CLINICAL_TRIALS research · 2015-04-08Clinical Trial Update: Grass Observational Study
Circassia Limited completed an observational study on grass pollen allergy presenting with rhinoconjunctivitis.
-
CLINICAL_TRIALS trial_result · 2014-07-25Clinical Trial Update: Regulatory T-cells After Subcutaneous Immunotherapy
A completed clinical trial evaluated regulatory T-cell responses after subcutaneous immunotherapy for grass pollen allergy.
-
CLINICAL_TRIALS trial_result · 2014-06-05Clinical Trial Update: Safety and Efficacy of Grass Pollen Allergoid in the Treatment of Allergic Rhinoconjunctivitis [Phase 3]
Phase 3 trial evaluating the safety and efficacy of Grass Pollen Allergoid for grass pollen allergy has been completed.
-
CLINICAL_TRIALS trial_result · 2014-01-24Clinical Trial Update: Safety and Efficacy of a Sublingual Specific Immunotherapy With an Extract of a Six Grass Pollen Mixture [Phase 3]
Phase 3 trial update evaluating the safety and efficacy of a sublingual six-grass pollen extract for grass pollen allergy; study completed.
-
CLINICAL_TRIALS trial_result · 2013-11-26Clinical Trial Update: ToleroMune Grass Follow on Study
Circassia Limited reports that the ToleroMune Grass follow-on clinical trial has completed.
-
CLINICAL_TRIALS trial_result · 2013-08-15Clinical Trial Update: ToleroMune Grass Exposure Unit Study [Phase 2]
A Phase 2 study of ToleroMune for grass pollen allergy and allergic rhinoconjunctivitis has completed.
-
CLINICAL_TRIALS trial_result · 2013-01-14Clinical Trial Update: Safety and Dose Finding Trial of BM32 in Subjects Suffering From Grass Pollen Allergy [Phase 2]
Phase 2 safety and dose-finding study of BM32 in subjects with grass pollen allergy has completed.
-
CLINICAL_TRIALS trial_result · 2012-11-19Clinical Trial Update: Compliance to the Treatment With GRAZAX® Tablets in Patients With Seasonal Grass Pollen Rhinoconjunctivitis [Phase 3]
Phase 3 trial assessing adherence to GRAZAX grass pollen immunotherapy in seasonal allergic rhinitis has completed.
-
CLINICAL_TRIALS trial_result · 2012-08-27Clinical Trial Update: Biological Standardization of Lolium Perenne Allergen Extract [Phase 2]
Phase 2 update on the biological standardization of Lolium perenne grass pollen allergen extract, sponsored by Laboratorios Leti, S.L., for …
-
CLINICAL_TRIALS trial_result · 2012-08-23Clinical Trial Update: Seasonal Allergic Rhinitis Study [Phase 2]
Phase 2 clinical trial update for Seasonal Allergic Rhinitis, sponsored by the University of East Anglia; the study addressing seasonal alle…
-
CLINICAL_TRIALS trial_result · 2012-08-21Clinical Trial Update: Biological Standardization of Poa Pratensis Allergen Extract [Phase 2]
Phase 2 clinical trial update on the biological standardization of Poa pratensis allergen extract for grass pollen allergy. The study status…
-
CLINICAL_TRIALS trial_result · 2011-08-30Clinical Trial Update: A Phase III Trial Assessing the Pharmacodynamic Effect and the Tolerability of Grazax Treatment [Phase 3]
This update notes the completion of a Phase III study evaluating the pharmacodynamic effects and tolerability of Grazax for grass pollen all…